For instance, a number of recent studies have reported that diverse TH subsets TH9, TH17 and TH22 and their main cytokines such as IL-9, IL-17 and IL-22 participate in the modulation of immune response in patients with CRC (91). This evidence concerns the gene IL17A and colorectal carcinoma.